HR Execs on the Move

First Investors Life Insur Co

www.firstinvestorslife.com

 
First Investors Life Insur Co is a New York, NY-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Pima County Workforce Investment Board

Pima County Workforce Investment Board is a Tucson, AZ-based company in the Business Services sector.

SSI Surgical Services

Surgical Services, Inc., is a leading provider of endoscopy services to acute care hospitals and ambulatory surgery centers. Our endoscopy specialists provide on-site assistance for all types of rigid endoscopy procedures. Additionally, SSI provides

Thames Television Ny Inc

Thames Television Ny Inc is one of the leading providers in Business Services. It is based in New York, NY. To find more information about Thames Television Ny Inc, please visit www.dltentertainment.com.

XtractedCBD

Xtracted CBD carries premium, high-quality CBD oil tinctures and CBD softgels. Visit our online store and browse our selection of CBD products, grown in the USA.

Satellos

Satellos is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Satellos was founded on the discovery that dysregulated muscle stem-cell polarity - a process that balances replenishment of muscle stem cells and production of specialized tissue cells- can lead to the inability of the body to properly repair and regenerate muscle throughout life. Satellos` lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease. Satellos believes defects in muscle regeneration play a critical underlying role in numerous muscle disorders spanning rare diseases through to mass market indications. Accordingly, Satellos applies its proprietary discovery platform, MyoReGenX, to identify regulatory pathways and drug candidates to treat muscle disorders where stem cell polarity is dysregulated.